The global lateral flow assay (LFA) market, valued at USD 4.3 billion in 2023, is projected to grow steadily at a CAGR of 4.7% during the forecast period, reaching USD 6.9 billion by 2033. This growth ...

he cell-based assays market is on a trajectory of sustained growth, driven by technological innovation and the expanding use of biologics in healthcare. VANCOUVER ...

Curve DAO (CRV) is emerging as one of the more notable decentralized finance (DeFi) tokens, with its decentralized exchange (DEX) focusing on stablecoins and liquidity pools. In recent years, as the ...

“Solar’s learning curve has never ended,” says Birch. “In fact, its growth rate has increased. When you combine this growth trend with the lower energy needed with electrification you get ...

The global next generation molecular assay market is poised for significant growth, with an expected valuation of USD 8,654.92 million by 2032, up from USD 4,976.30 million in 2021, reflecting a 5.16% ...

High Cost Associated with Cell-Based Assays Likely to Challenge Industry Growth The development and deployment of sophisticated cell-based assays impose a considerable financial burden, acting as a ...